<bill session="117" type="s" number="1692" updated="2023-01-11T13:50:11Z">
  <state datetime="2021-05-19">REFERRED</state>
  <status>
    <introduced datetime="2021-05-19"/>
  </status>
  <introduced datetime="2021-05-19"/>
  <titles>
    <title type="display">Concentrating on High-Value Alzheimer&#226;&#8364;&#8482;s Needs to Get to an End (CHANGE) Act of 2021</title>
    <title type="official" as="introduced">A bill to provide better care and outcomes for Americans living with Alzheimer's disease and related to dementias and their caregivers, while accelerating progress toward prevention strategies, disease modifying treatments, and, ultimately, a cure.</title>
    <title type="short" as="introduced">Concentrating on High-Value Alzheimer&#226;&#8364;&#8482;s Needs to Get to an End (CHANGE) Act of 2021</title>
  </titles>
  <sponsor bioguide_id="C001047"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2022-06-09"/>
    <cosponsor bioguide_id="C001070" joined="2021-07-14"/>
    <cosponsor bioguide_id="H001061" joined="2021-10-21"/>
    <cosponsor bioguide_id="H001079" joined="2021-07-14"/>
    <cosponsor bioguide_id="K000383" joined="2022-06-09"/>
    <cosponsor bioguide_id="K000367" joined="2022-06-09"/>
    <cosponsor bioguide_id="M000639" joined="2021-05-19"/>
    <cosponsor bioguide_id="P000595" joined="2022-09-12"/>
    <cosponsor bioguide_id="S001181" joined="2022-06-09"/>
    <cosponsor bioguide_id="S001191" joined="2021-10-21"/>
    <cosponsor bioguide_id="S000770" joined="2021-05-19"/>
    <cosponsor bioguide_id="T000464" joined="2021-09-21"/>
    <cosponsor bioguide_id="T000476" joined="2021-12-16"/>
    <cosponsor bioguide_id="V000128" joined="2021-12-16"/>
    <cosponsor bioguide_id="W000437" joined="2021-05-19"/>
  </cosponsors>
  <actions>
    <action datetime="2021-05-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-05-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="3354" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Aging"/>
    <term name="Congressional oversight"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care quality"/>
    <term name="Health information and medical records"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Neurological disorders"/>
  </subjects>
  <amendments/>
  <summary date="2021-10-19T16:19:29Z" status="Introduced in Senate">Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2021 This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports. Additionally, the Centers for Medicare &amp; Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.</summary>
</bill>
